Dr. Salin Eliyas, Consultant at the Health Technology Assessment (HTA) Unit, represented PROPUL Evidence LLP at the workshop titled “Converging Perspectives: A Cross-Sectoral Workshop on One Health,” held from 30 July to 1 August 2026 at the Indian Institute of Science (IISc), Bengaluru. The workshop brought together professionals, researchers, policymakers, [...]
PROPUL Evidence LLP is pleased to share the successful completion of the session titled “From Question to Synthesis: Conducting Systematic Reviews in Medical Education,” delivered by Dr. Yuvaraj Krishnamoorthy, CEO & Managing Partner, as part of the Indian Association of Preventive and Social Medicine (IAPSM) Online Medical Education Talk Series [...]
PROPUL Evidence LLP is pleased to announce the successful completion of ACS METAQUEST 2026, a two-day workshop on Systematic Review and Meta-analysis, conducted at A.C.S. Medical College and Hospital, Chennai. The workshop was facilitated by our expert team, including Dr. Yuvaraj Krishnamoorthy (CEO & Managing Partner), Dr. Dhanajayan Govindan, and [...]
PROPUL Evidence LLP is pleased to announce a significant milestone in advancing global health research and evidence synthesis. The World Health Organization (WHO) has officially released its technical report titled “Key Ingested Per- and Polyfluoroalkyl Substances (PFAS) and Their Health Effects: Landscape Review.” Our expert team at PROPUL Evidence LLP [...]
We are proud to share that Dr. Yuvaraj Krishnamoorthy has been independently verified and ranked among the World’s Top 5% Scientists in the 2025 SciRank Global Registry. This recognition reflects his ongoing contributions to research and his commitment to advancing scientific excellence through evidence-based work. The certificate, issued by SciRank [...]